These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28555364)

  • 1. Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro.
    Dharmapatni AASSK; Algate K; Coleman R; Lorimer M; Cantley MD; Smith MD; Wechalekar MD; Crotti TN
    Inflammation; 2017 Oct; 40(5):1566-1575. PubMed ID: 28555364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.
    Crotti TN; Dharmapatni AA; Alias E; Zannettino AC; Smith MD; Haynes DR
    Arthritis Res Ther; 2012 Nov; 14(6):R245. PubMed ID: 23146195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis.
    Herman S; Müller RB; Krönke G; Zwerina J; Redlich K; Hueber AJ; Gelse H; Neumann E; Müller-Ladner U; Schett G
    Arthritis Rheum; 2008 Oct; 58(10):3041-50. PubMed ID: 18821671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
    Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
    Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
    J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis.
    Kim HR; Kim KW; Kim BM; Jung HG; Cho ML; Lee SH
    Arthritis Rheumatol; 2014 Mar; 66(3):538-48. PubMed ID: 24574213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
    Romas E; Gillespie MT; Martin TJ
    Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
    Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis.
    Takeshita A; Nishida K; Yoshida A; Nasu Y; Nakahara R; Kaneda D; Ohashi H; Ozaki T
    PLoS One; 2021; 16(7):e0254268. PubMed ID: 34234380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis.
    Wu Y; Liu J; Feng X; Yang P; Xu X; Hsu HC; Mountz JD
    Arthritis Rheum; 2005 Oct; 52(10):3257-68. PubMed ID: 16200600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
    Nakano K; Okada Y; Saito K; Tanaka Y
    Arthritis Rheum; 2004 Aug; 50(8):2450-8. PubMed ID: 15334457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.
    Kim JY; Lee EY; Lee EB; Lee YJ; Yoo HJ; Choi J; Song YW
    Arthritis Res Ther; 2012 Aug; 14(4):R187. PubMed ID: 22901757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.
    Kim KW; Kim HR; Kim BM; Cho ML; Lee SH
    Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclasts are not activated in middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ikezaki S; Ohbuchi T; Hashida K; Sakai A
    J Bone Miner Metab; 2016 Mar; 34(2):193-200. PubMed ID: 25796629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.
    Revu S; Neregård P; af Klint E; Korotkova M; Catrina AI
    Arthritis Res Ther; 2013; 15(6):R205. PubMed ID: 24295447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.